The Use of Microbial Accessible and Fermentable Carbohydrates and/or Butyrate as Supportive Treatment for Patients With Coronavirus SARS-CoV-2 Infection. | Front Med (Lausanne);7: 292, 2020. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

The Use of Microbial Accessible and Fermentable Carbohydrates and/or Butyrate as Supportive Treatment for Patients With Coronavirus SARS-CoV-2 Infection.

Archer, Douglas L; Kramer, Dean C.

Archer DL; Food Science and Human Nutrition Department, Institute of Food and Agricultural Science, University of Florida, Gainesville, FL, United States.
Kramer DC; Gastroenterology, Kramer Medical Clinic, Gainesville, FL, United States.

Front Med (Lausanne) ; 7: 292, 2020.

Article in English | MEDLINE | ID: covidwho-615498

Keywords

SCFAs; adjunct therapy; anti-inflammatory; butyrate; cytokine storm

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Front Med (Lausanne) Year: 2020 Document Type: Article Affiliation country: Fmed.2020.00292

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Front Med (Lausanne) Year: 2020 Document Type: Article Affiliation country: Fmed.2020.00292